Animal Pharm is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PEOPLE - AVMA (American Veterinary Medical Association) names Dr Ron DeHaven executive vice-president:

Dr Ron DeHaven is to become executive vice-president of the American Veterinary Medical Association (AVMA). He has been with the Animal and Plant Health Inspection Service arm of the US Department of Agriculture since 1979 and for the past three years has served as administrator. He will succeed Dr Bruce Little, who has been the AVMA executive vice-president since 1996 and will be retiring later this year. AVMA president Dr Roger Mahr said: "I have a great deal of respect and admiration for Dr DeHaven's global perspective on the continuing convergence of animal health, human health and ecosystem health. This global perspective makes him uniquely qualified to serve as executive vice-president." Dr DeHaven was awarded the Secretary's Honor Award in 2003 and 2004 for his handling of chronic wasting disease and bovine spongiform encephalopathy in the country, and also received the AVMA's Meritorious Service Award for his contributions to the veterinary profession.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AP011802

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel